7Baggers
 (blte) as a liquidity pulse for institutional tactics  news.stocktradersdaily.com Sun, 16 Nov 2025 02:32:01 GMT
 Belite Bio ADR’s Earnings Call: Progress Amid Rising Costs  TipRanks Wed, 12 Nov 2025 00:33:38 GMT
 Belite Bio, Inc (NASDAQ:BLTE) Q3 2025 Earnings Call Transcript  Insider Monkey Tue, 11 Nov 2025 13:49:32 GMT
 belite bio q3 2025 earnings call transcript  MarketBeat Tue, 11 Nov 2025 11:13:53 GMT
 Belite Bio reports Q3 EPS (65c), consensus (49c)  TipRanks Tue, 11 Nov 2025 09:41:20 GMT
 Belite Bio Advances in Retinal Disease Therapeutics  TipRanks Tue, 11 Nov 2025 04:35:56 GMT
 earnings call transcript: belite bio q3 2025 reports increased r&d expenses  Investing.com Nigeria Tue, 11 Nov 2025 03:35:59 GMT
 belite bio q3 2025 earnings call transcript  MarketBeat Mon, 10 Nov 2025 23:01:05 GMT
 belite bio, inc (blte) q3 fy2025 earnings call transcript  Yahoo Finance Mon, 10 Nov 2025 21:30:00 GMT
 Belite Bio, Inc. ADR Shares Surge Amid Trial Success  TipRanks Mon, 10 Nov 2025 17:59:24 GMT
 Belite Bio stock reaches all-time high at 117.95 USD  Investing.com Mon, 10 Nov 2025 15:25:28 GMT
 Belite Bio Doubles Down On R&D Spending Despite Growing Losses  Finimize Mon, 10 Nov 2025 14:29:11 GMT
 Belite Bio Q3 net loss widens on higher R&D expenses  TradingView Mon, 10 Nov 2025 13:12:02 GMT
 belite bio reports q3 eps (65c), consensus (49c)  TipRanks Mon, 10 Nov 2025 08:00:00 GMT
 belite bio (blte) projected to post quarterly earnings on tuesday  MarketBeat Wed, 05 Nov 2025 17:14:37 GMT
 belite bio (nasdaq:blte) hits new 52-week high - should you buy?  MarketBeat Tue, 04 Nov 2025 10:24:09 GMT
 belite bio at deutsche bank conference: advancing stargardt treatment  Investing.com Tue, 04 Nov 2025 08:00:00 GMT

Belite Bio, Inc
(NASDAQ:BLTE) 

BLTE stock logo

Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular degeneration and autosomal recessive stargardt diseases. The company is headquartered in San Diego, California.

Founded: 2016
IPO Price: $6 (Apr 29, 2022)
CEO / Founder: Dr. Tom Lin 
Sector: Technology
Industry: General

Share this website to your friends